Reynoutrin activates Sirt1/Foxo3a and Nrf2 pathway via targeting Fyn to ameliorate diabetic nephropathy
{{output}}
Background: Diabetic nephropathy (DN) is a major complication of diabetes, associated with high mortality and disability rates. Fyn kinase has emerged as a promising therapeutic target for DN due to its antioxidant properties. Ho... ...
